News

2025

Proteovista continues their 5-year collaboration on "Mechanisms of Variant ER-alpha Function in Breast Cancer" with the University of Wisconsin-Madison using our SNAP DNA binding technology.

Proteovista is selected for a talk on our novel DNA synthesis technology at the AGTD meeting (Farmington, CT).

Proteovista is awarded an SBIR Phase I to develop novel methods to synthesize error-free DNA.

Proteovista is awarded a $600,000 NIH contract to develop novel aptamers to detect immune proteins.

Proteovista is awarded a SBIR Phase I from IMAT to develop our high throughput APT-SNAP platform for rapid identification of nuclease-resistant RNA aptamers against p53 missense mutations
Proteovista is awarded an R21 grant (IMAT) to develop our high content SNAP-X protein array.

The National Cancer Institute awarded Proteovista's SBIR Grant, "Site-Specific Incorporation of Phosphorylation Modifications on the SNAP-Tide High Density Peptide Array."

Proteovista is awarded a SBIR Advance Phase I Match Grant from the Wisconsin Center for Technology Commercialization, August 2017.

Proteovista presented "High Throughput Analysis of the DNA Binding Specificity of Estrogen Receptor and Estrogen Related Receptor Complexes," Keystone Symposium Nuclear Receptors in Snowbird, UT.

Proteovista presented invited talk to U.S. Representative Mark Pocan at University Research Park.
Proteovista presented “High Density Peptide Arrays for Cancer-Related Post-Translational Modifications" at the IMAT Symposium in Bethesda, MD.
Proteovista presented "Discovery of Small Molecule Modulators Targeting Estrogen Receptor-FoxA1-DNA Interactions Using SNAP-Screen DNA Arrays" at FASEB meeting in Big Sky, MT.
Proteovista awarded Wisconsin Small Business Innovation Award for Outstanding Achievements.

The National Institutes of Health has awarded Proteovista a three-year, $643,000 grant to develop a new microarray platform for identifying biomarkers associated with various cardiovascular diseases.
"SNP-SNAP Binding Arrays Reveal SNPs that Modulate Transcription Factor Interactions in Prostate Cancer" selected for a talk at the ENDO Society meeting in Chicago.
Proteovista presented "High Throughput Strategies to Identify Small Molecule Modulators of Estrogen Receptor - DNA Interactions" at the Keystone Symposia in Taos, New Mexico.
Proteovista is awarded a three year R21 grant by the NIH for the development of a high density peptide array to study human post-translational modifications.